Skip to main content
. 2011 Aug 26;13(4):576–584. doi: 10.1208/s12248-011-9297-2

Fig. 3.

Fig. 3

Model-based prediction a and description b of mean UGE pharmacodynamics of dapagliflozin in healthy subjects following single doses as obtained from the literature (26). Symbols represent doses of 0 (asterisk), 2.5 (plus sign), 10 (triangle), 50 (diamond), 100 (circle), and 250 mg (multiplication sign). Lines represent model predictions a and fits b